WE STAY ON TOP OF INDUSTRY TRENDS
According to the latest research report released by Technavio, the global heparin market will likely reach over USD 5 billion by 2020.
This report titled "Global Heparin Market 2016-2020", provides an in-depth analysis of the market in terms of revenue and emerging trends. To calculate the market size, the report considers revenue generated from the sales of branded and generics used to treat disorders.
The use of heparin may lead to bleeding, which could be managed using protamine, an antidote for heparin-related bleeding. However, protamine was found to have side effects such as hypertension and decreased heart rate. Hence, extensive research was done to develop agents with lesser side-effects. This led to the development of universal heparin reversal agents (UHRAs) by researchers of The University of British Columbia, Canada. These are synthetic dendritic polymers, which neutralizes anticoagulant effects, said Barath Palada, one of Technavios lead industry analysts for healthcare and life sciences.READ MORE